237 related articles for article (PubMed ID: 31682964)
1. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
[TBL] [Abstract][Full Text] [Related]
2. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and
Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM
Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545
[TBL] [Abstract][Full Text] [Related]
3. Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody - Bevacizumab - and Triamcinolone acetonide for combined therapy in neovascular ocular pathologies.
Formica ML; Legeay S; Bejaud J; Montich GG; Ullio Gamboa GV; Benoit JP; Palma SD
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111398. PubMed ID: 33321575
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
Guo D; Li Q; Sun Y; Guo J; Zhao Q; Yin X; Wei H; Wu S; Bi H
Nanotechnology; 2019 Apr; 30(16):165702. PubMed ID: 30641491
[TBL] [Abstract][Full Text] [Related]
5. Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity.
Nirbhavane P; Sharma G; Singh B; Begum G; Jones MC; Rauz S; Vincent R; Denniston AK; Hill LJ; Katare OP
Colloids Surf B Biointerfaces; 2020 Jun; 190():110902. PubMed ID: 32143010
[TBL] [Abstract][Full Text] [Related]
6. Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
Li W; He B; Dai W; Zhang Q; Liu Y
Int Ophthalmol; 2014 Jun; 34(3):465-76. PubMed ID: 23868505
[TBL] [Abstract][Full Text] [Related]
7. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation.
Huang J; Yu X; Zhou Y; Zhang R; Song Q; Wang Q; Li X
Int J Pharm; 2018 Nov; 551(1-2):223-231. PubMed ID: 30213683
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
[TBL] [Abstract][Full Text] [Related]
10. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.
Korodi T; Lachmann B; Kopelent-Frank H
Pharmazie; 2010 Dec; 65(12):860-6. PubMed ID: 21284253
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
13. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
[TBL] [Abstract][Full Text] [Related]
14. Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration.
Formica ML; Awde Alfonso HG; Paredes AJ; Melian ME; Camacho NM; Faccio R; Tártara LI; Palma SD
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840006
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells.
Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z
AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292
[TBL] [Abstract][Full Text] [Related]
16. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
Sabzevari A; Adibkia K; Hashemi H; Hedayatfar A; Mohsenzadeh N; Atyabi F; Ghahremani MH; Dinarvand R
Eur J Pharm Biopharm; 2013 May; 84(1):63-71. PubMed ID: 23295645
[TBL] [Abstract][Full Text] [Related]
17. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.
Kambhampati SP; Mishra MK; Mastorakos P; Oh Y; Lutty GA; Kannan RM
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):239-49. PubMed ID: 25701805
[TBL] [Abstract][Full Text] [Related]
18. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
19. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
[TBL] [Abstract][Full Text] [Related]
20. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery.
Altamirano-Vallejo JC; Navarro-Partida J; Gonzalez-De la Rosa A; Hsiao JH; Olguín-Gutierrez JS; Gonzalez-Villegas AC; Keller BC; Bouzo-Lopez L; Santos A
J Ocul Pharmacol Ther; 2018 Jun; 34(5):416-425. PubMed ID: 29584529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
